|
End-of-day quote
Shenzhen S.E.
2026-08-25
|
5-day change | 1st Jan Change | ||
| 172.23 CNY | +10.00% |
|
-2.83% | +85.33% |
Company Valuation: Asymchem Laboratories (Tianjin) Co., Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 111,228 | 52,704 | 41,387 | 26,238 | 32,605 | 59,677 | - | - |
| Change | - | -52.62% | -21.47% | -36.6% | 24.27% | 83.03% | - | - |
| Enterprise Value (EV) 1 | 105,383 | 47,524 | 34,318 | 20,491 | 26,337 | 54,970 | 55,950 | 56,722 |
| Change | - | -54.9% | -27.79% | -40.29% | 28.53% | 108.72% | 1.78% | 1.38% |
| P/E | 99.1x | 16.4x | 18.5x | 28.3x | 29.4x | 45x | 34.1x | 28.1x |
| PBR | 9.07x | 3.5x | 2.46x | 1.66x | 1.9x | 3.29x | 3.07x | 2.83x |
| PEG | - | 0x | -0.6x | -0.5x | 1.7x | 2.3x | 1.1x | 1.3x |
| Capitalization / Revenue | 24x | 5.15x | 5.29x | 4.52x | 4.89x | 7.38x | 6.1x | 5.04x |
| EV / Revenue | 22.7x | 4.65x | 4.39x | 3.53x | 3.95x | 6.8x | 5.72x | 4.79x |
| EV / EBITDA | 75.3x | 13.6x | 11.2x | 16.1x | 15.1x | 26.7x | 21.6x | 17.8x |
| EV / EBIT | 88.4x | 15.2x | 13.3x | 19x | 22.5x | 35.2x | 27.7x | 22.9x |
| EV / FCF | -68.1x | 41.8x | 14.6x | 164x | 192x | -88.1x | 114x | 44.1x |
| FCF Yield | -1.47% | 2.39% | 6.84% | 0.61% | 0.52% | -1.14% | 0.87% | 2.27% |
| Dividend per Share 2 | 0.5714 | 1.8 | 1.8 | 1.1 | 1.3 | 1.379 | 1.821 | 2.161 |
| Rate of return | 0.18% | 1.22% | 1.55% | 1.45% | 1.4% | 0.81% | 1.07% | 1.27% |
| EPS 2 | 3.136 | 9 | 6.26 | 2.69 | 3.16 | 3.79 | 4.998 | 6.081 |
| Distribution rate | 18.2% | 20% | 28.8% | 40.9% | 41.1% | 36.4% | 36.4% | 35.5% |
| Net sales 1 | 4,639 | 10,230 | 7,825 | 5,805 | 6,670 | 8,085 | 9,785 | 11,831 |
| EBITDA 1 | 1,399 | 3,498 | 3,058 | 1,274 | 1,744 | 2,062 | 2,587 | 3,186 |
| EBIT 1 | 1,192 | 3,136 | 2,571 | 1,079 | 1,169 | 1,562 | 2,018 | 2,475 |
| Net income 1 | 1,069 | 3,302 | 2,269 | 949 | 1,133 | 1,364 | 1,802 | 2,329 |
| Net Debt 1 | -5,846 | -5,180 | -7,069 | -5,747 | -6,268 | -4,707 | -3,727 | -2,955 |
| Reference price 2 | 310.71 | 148.00 | 116.10 | 76.09 | 92.93 | 170.64 | 170.64 | 170.64 |
| Nbr of stocks (in thousands) | 368,307 | 364,755 | 364,426 | 354,879 | 359,442 | 359,630 | - | - |
| Announcement Date | 3/30/22 | 3/30/23 | 3/28/24 | 3/28/25 | 3/30/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 45.47x | 6.86x | 26.9x | 0.8% | 8.95B | ||
| 33.86x | 12.29x | 24.9x | 0.58% | 1,060B | ||
| 30.03x | - | - | 1.99% | 651B | ||
| 33.56x | 7.77x | 16.15x | 2.61% | 465B | ||
| 20.52x | 4.87x | 12.06x | 2.71% | 365B | ||
| 22.43x | 5.77x | 14.31x | 2.77% | 300B | ||
| 21.39x | 4.38x | 12.52x | 2.01% | 258B | ||
| 27.85x | 7.18x | 12.75x | 2.29% | 238B | ||
| 13.86x | 4.91x | 10.27x | 3.71% | 210B | ||
| -45.25x | 6.53x | 25.49x | 2.23% | 184B | ||
| Average | 20.37x | 6.73x | 17.26x | 2.17% | 373.94B | |
| Weighted average by Cap. | 24.71x | 8.18x | 18.11x | 1.93% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 002821 Stock
- Valuation Asymchem Laboratories (Tianjin) Co., Ltd.
Select your edition
All financial news and data tailored to specific country editions
















